Yuli Li Selected Research

Yuli Li Research Topics

6	Neoplasms (Cancer) 01/2022 - 03/2004
2	Chronic Pain 10/2022 - 09/2015
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2013
2	Wounds and Injuries (Trauma) 01/2013 - 08/2012
1	Opioid-Related Disorders (Opiate Addiction) 10/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Infertility (Sterility) 01/2022
1	Epilepsy (Aura) 12/2021
1	Mental Disorders (Mental Disorder) 07/2021
1	Schizophrenia (Dementia Praecox) 07/2021
1	Reinfection 06/2021
1	Gastritis 06/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Adenocarcinoma 01/2019
1	Alcoholism (Alcohol Abuse) 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Craniocerebral Trauma (Head Injury) 01/2018
1	Chromosome Breakage 01/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2014
1	Reperfusion Injury 01/2014
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Toxic Optic Neuropathy 02/2012
1	Melanoma (Melanoma, Malignant) 03/2011
1	Necrosis 04/2002
1	Massive Hepatic Necrosis 04/2002

2	Opioid Analgesics (Opioids)IBA 10/2022 - 09/2015
2	LipopolysaccharidesIBA 11/2014 - 04/2002
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	BuffersIBA 01/2022
1	alectinibIBA 01/2022
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 02/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Glycyrrhetinic Acid (Po 12)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Pharmaceutical PreparationsIBA 09/2015
1	VaccinesIBA 11/2014
1	Monoclonal AntibodiesIBA 11/2014
1	Sheng-Nao-KangIBA 01/2014
1	Celecoxib (Celebrex)FDA Link 05/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2013
1	15-hydroxyprostaglandin dehydrogenaseIBA 05/2013
1	Dinoprostone (PGE2)FDA Link 05/2013
1	HydrogelsIBA 01/2013
1	Ointments (Pastes)IBA 08/2012
1	PowdersIBA 08/2012
1	Polymethyl Methacrylate (Sol)IBA 08/2012
1	Petrolatum (Vaseline)FDA Link 08/2012
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 02/2012
1	SuspensionsIBA 02/2012
1	Retinaldehyde (Retinal)IBA 03/2011
1	9-((2-phosphonylmethoxy)ethyl)guanineIBA 03/2011
1	AgarIBA 03/2004
1	Fas Ligand Protein (Fas Ligand)IBA 04/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2002
1	oxymatrineIBA 04/2002
1	GalactosamineIBA 04/2002

4	Therapeutics 01/2022 - 05/2013
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 06/2021
1	Precision Medicine 07/2021